UNSPSC 51453102: Oxantel

This classification denotes a pyrantel analog and antinematodal agent with the molecular formula C13H16N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 94AJJ30D9E, chemically known as phenol, 3-(2-(1,4,5,6-tetrahydro-1-methyl-2-pyrimidinyl)ethenyl)-, (e)- but generally known as oxantel, which bears US NIH Compound Identifier 5281087. European Medicines Agency schedules Oxantel in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09497MIG.

UNSPSC 51453102 Oxantel is a Commodity code that does not align with the state and local procurement opportunities currently tagged under it. The code nominally refers to a specific antihelmintic pharmaceutical product, but the recent solicitations—spanning naloxone (an opioid antagonist), generic multi-source pharmaceuticals and OTC products, and first-aid medical supplies—show no direct relationship to oxantel itself. The mismatch suggests either miscoding at the source-agency level or that this code sees little relevant recent activity in state and local procurement.

The opportunities that do carry this code designation span three distinct types of issuing bodies: a county health department (Seminole County, Florida), a state health agency (Texas Health and Human Services Commission), a municipal fire and rescue department (City of Tampa), and a multi-state cooperative purchasing alliance (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP, serving Minnesota and Oregon). Representative recent activity includes Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries (due Jul 26, 2023); the City of Tampa's IFB for 169 line items of medical and first-aid supplies for the Fire Department Rescue Division (due Mar 13, 2026, sheltered to certified Small Local Business Enterprises with an estimated value of $700,000); and MMCAP's RFP for generic multi-source pharmaceuticals and OTC products to be supplied through three authorized wholesalers with proposals due Mar 26, 2026. Geographic activity in the source centers on Florida, Texas, Minnesota, and Oregon, though the coding inconsistency limits confidence in drawing broader geographic conclusions. Firms pursuing pharmaceutical, naloxone, or medical-supply opportunities should verify actual UNSPSC coding at pre-bid rather than relying on posted taxonomies for this code.